Immediate Impact
49 standout
Citing Papers
Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?
2024 Standout
Migraine: from pathophysiology to treatment
2023 Standout
Works of Raymond Schwartz being referenced
Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
2019
Emotional conversations in Parkinson’s disease
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Raymond Schwartz | 90 | 48 | 15 | 32 | 16 | 188 | |
| Kogulavadanan Arumaithurai | 47 | 64 | 9 | 27 | 16 | 225 | |
| Frederick M. Vincent | 104 | 57 | 5 | 33 | 20 | 234 | |
| W. Meese | 94 | 32 | 9 | 16 | 13 | 223 | |
| Seung-Hwan Lee | 103 | 57 | 8 | 64 | 31 | 281 | |
| Philip S. Bergman | 61 | 49 | 4 | 59 | 21 | 284 | |
| Vesper Ramos | 125 | 27 | 7 | 28 | 21 | 243 | |
| Emine Genç | 47 | 108 | 7 | 30 | 23 | 239 | |
| Pedro Coelho | 113 | 62 | 23 | 30 | 12 | 219 | |
| C. Ori | 70 | 59 | 9 | 38 | 24 | 274 | |
| Marco Masina | 49 | 91 | 15 | 66 | 19 | 266 |
All Works
Loading papers...